Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (371-380 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Antimicrobial Chemotherapy|January 31, 2012
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)Helio S Sader, Susanne Paukner, Zrinka Ivezic-Schoenfeld, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997)Helio S. Sader, Ronald N. Jones, Patricia L. Winokur, et al.
International Journal of Antimicrobial Agents|March 10, 2010
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolatesDavid J Farrell, Helio S Sader, Mariana Castanheira, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 21, 2017
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census DivisionsMichael A Pfaller, Helio S Sader, Robert K Flamm, et al.
International Journal of Antimicrobial Agents|February 4, 2023
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Diagnostic Microbiology and Infectious Disease|February 25, 2015
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013Helio S Sader, David J Farrell, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2023
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanismsSusanne Paukner, Rodrigo E Mendes, S J Ryan Arends, et al.
Journal of Clinical Microbiology|November 10, 2006
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter sppRonald N Jones, Mary Jane Ferraro, L Barth Reller, et al.
Journal of Clinical Microbiology|November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolidRodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|July 13, 2007
Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitalsAndrea S Pereira, Soraya S Andrade, Jussimara Monteiro, et al.
Pageof 42

Showing results (371-380 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|January 31, 2012
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)Helio S Sader, Susanne Paukner, Zrinka Ivezic-Schoenfeld, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997)Helio S. Sader, Ronald N. Jones, Patricia L. Winokur, et al.
International Journal of Antimicrobial Agents|March 10, 2010
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolatesDavid J Farrell, Helio S Sader, Mariana Castanheira, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 21, 2017
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census DivisionsMichael A Pfaller, Helio S Sader, Robert K Flamm, et al.
International Journal of Antimicrobial Agents|February 4, 2023
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Diagnostic Microbiology and Infectious Disease|February 25, 2015
Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013Helio S Sader, David J Farrell, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2023
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanismsSusanne Paukner, Rodrigo E Mendes, S J Ryan Arends, et al.
Journal of Clinical Microbiology|November 10, 2006
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter sppRonald N Jones, Mary Jane Ferraro, L Barth Reller, et al.
Journal of Clinical Microbiology|November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolidRodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|July 13, 2007
Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitalsAndrea S Pereira, Soraya S Andrade, Jussimara Monteiro, et al.
Pageof 42